Login / Signup
Regarding Mastorino et al.'s "Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients".
Sebastian Yu
James Cheng-Chung Wei
Published in:
Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Keyphrases
</>
end stage renal disease
rheumatoid arthritis
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
ankylosing spondylitis
patient reported outcomes
ulcerative colitis
hidradenitis suppurativa